covid 19 News and Research

RSS

Electronic interventions more effective than face to face psychotherapy

Cognitive behavioral therapy delivered electronically to treat people with depression is more effective than face to face, suggests an evidence review led by McMaster University.

8 Jul 2020

Researchers propose novel approach to limit life-threatening complications related to COVID-19

Patients with severe COVID-19 frequently experience a life-threatening immune reaction, sometimes called a cytokine storm, which can lead to respiratory failure, organ damage and potentially death.

8 Jul 2020

COVID-19 cases and deaths found to be higher among U.S. prison residents than general population

A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population, with a prisoner case rate of 3,251 per 100,000 residents as compared to 587 cases per 100,000 in the general population.

8 Jul 2020

Columbia behavioral scientist uses data science to confront healthcare inequality

Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.

8 Jul 2020

Lung physiology and immune function could spare children from severe COVID-19

Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at The University of Texas Health Science Center at Houston and Baylor College of Medicine, who teamed up to investigate the disparity.

8 Jul 2020

$50 million NIST funding to support U.S. manufacturers in their response to COVID-19

The U.S. Department of Commerce's National Institute of Standards and Technology (NIST) has awarded a total of $50 million in emergency funding to support U.S. manufacturers in their response to the COVID-19 pandemic.

8 Jul 2020

UofSC researchers win NIH grant to develop data-driven system to track COVID-19

University of South Carolina researchers from its Big Data Health Science Center initiative have received $1.25 million in grant funding from the NIH National Institute of Allergy and Infectious Diseases (NIAID) to develop a data-driven system to track COVID-19 in South Carolina.

8 Jul 2020

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Jul 2020

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

8 Jul 2020

Study links fermented vegetable consumption to low COVID-19 mortality

An intriguing new study by researchers in Europe suggests that coronavirus disease 2019 (COVID-19) mortality rates are likely to be lower in countries where diets are rich in fermented vegetables.

8 Jul 2020

Tuberculosis vaccine may play a significant role in mitigating COVID-19 mortality rates

One of the emerging questions about the coronavirus that scientists are working to understand is why developing countries are showing markedly lower rates of mortality in COVID-19 cases than expected.

8 Jul 2020

Brain complications linked to COVID-19 found to be occurring across the globe

Cases of brain complications linked to COVID-19 are occurring across the globe, a new review by University of Liverpool researchers has shown.

8 Jul 2020

Community coronavirus testing in England shows lockdown had "intended effect"

UK researchers say the proportion of people testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) significantly declined in England between 26 April and 28 June 2020.

8 Jul 2020

Fred Hutch joins new clinical trials network to fight COVID-19

Fred Hutchinson Cancer Research Center has been named the coordinating center for vaccine clinical trials of the COVID-19 Prevention Network.

8 Jul 2020

Small molecule drugs binding Mac1 domain of SARS-CoV-2

Now, an intriguing new study out of the University of Wisconsin-Milwaukee reveals that numerous small molecule drugs like the proton pump inhibitors omeprazole and rabeprazole bind the important Mac1 domain on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.

8 Jul 2020

Researchers isolate potent SARS-CoV-2 neutralizing antibodies

An important line of defense in the fight against the new coronavirus SARS-CoV-2 is the formation of neutralizing antibodies.

8 Jul 2020

New machine learning tool identifies US counties at higher risk for COVID deaths

The task of controlling the COVID-19 pandemic nationwide and predicting where cases will spike next and which areas may have high mortality rates remains daunting for scientists and public officials.

8 Jul 2020

Study: Cellular therapy can improve critical cases of COVID-19

A cellular therapy tested on 13 intubated patients with mechanical ventilation has shown to be efficient for the clinical improvement of critical cases of COVID-19.

8 Jul 2020

COVID cuts a lethal path through San Quentin’s death row

The old men live in cramped spaces and breathe the same ventilated air. Many are frail, laboring with heart disease, liver and prostate cancer, tuberculosis, dementia. And now, with the coronavirus advancing through their ranks, they are falling one after the next.

8 Jul 2020

Rapid COVID-19 diagnostic infection testing

Porvair Sciences reports on the Vyon porous plastic filters it is supplying to University of Cambridge spinout company - Diagnostics for the Real World for their game-changing SAMBA II machine that provides diagnosis of COVID-19 infection in under 90 minutes.

From Porvair Sciences Limited 8 Jul 2020